Providence Therapeutics Company
.jpg)
Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat ovarian cancer.
Founded Date:
2015-01-01
Total Funding:
$3 476 087
Last Funding Type:
Venture - Series Unknown
Industry:
Women Cancer Treatment
Headquarters:
Toronto, Ontario, Canada
Last Funding Date:
2020-07-23